×
Pfizer Revenue 2012-2026 | PFE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Pfizer revenue for the twelve months ending March 31, 2026 was
$63.315B
, a
1.36% increase
year-over-year.
Pfizer annual revenue for 2025 was
$62.579B
, a
1.65% decline
from 2024.
Pfizer annual revenue for 2024 was
$63.627B
, a
6.84% increase
from 2023.
Pfizer annual revenue for 2023 was
$59.553B
, a
41.14% decline
from 2022.
View More
Pfizer Revenue 2012-2026 | PFE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Pfizer annual revenue for 2025 was
$62.579B
, a
1.65% decline
from 2024.
Pfizer annual revenue for 2024 was
$63.627B
, a
6.84% increase
from 2023.
Pfizer annual revenue for 2023 was
$59.553B
, a
41.14% decline
from 2022.
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$887.6B
Johnson & Johnson (JNJ)
$574.4B
AbbVie (ABBV)
$367.7B
Roche Holding AG (RHHBY)
$318.8B
Merck (MRK)
$299.9B
Novartis AG (NVS)
$294B
Novo Nordisk (NVO)
$167.5B
Sanofi (SNY)
$114B
Bayer (BAYRY)
$46.2B
Innoviva (INVA)
$1.8B